Filing Flows › SBC Medical Group Holdings (SBC) › Stock forecast & fair value
SBC Medical Group Holdings (SBC) stock forecast and price target
SBC Medical Group Holdings (SBC) trades at $5.04. 4 analysts' median price target is $8.50 (+69%), from $7.00 to $11.00.
SBC Medical Group Holdings' latest quarter
SBC Medical Group Holdings, Q2 2026: revenue $49.2M (+13% year over year), operating margin 38.5%, net earnings $10.7M, operating cash flow $22.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SBC stock?
The median of 4 analysts' 12-month targets is $8.50, +69% from $5.04; the range is $7.00 to $11.00. The average rating is strong buy.
Does SBC Medical Group Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is SBC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.